KONINKLIJKE PHILIPS NV (PHI1.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:PHI1 - NL0000009538 - Common Stock
25.41 EUR
+0.1 (+0.4%)
PHI1 gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 68 industry peers in the Health Care Equipment & Supplies industry. PHI1 has a bad profitability rating. Also its financial health evaluation is rather negative. PHI1 has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year PHI1 was profitable.
PHI1 had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: PHI1 reported negative net income in multiple years.
Of the past 5 years PHI1 4 years had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 0.63%, PHI1 is doing worse than 63.24% of the companies in the same industry.
With a Return On Equity value of 1.56%, PHI1 is not doing good in the industry: 63.24% of the companies in the same industry are doing better.
PHI1 has a Return On Invested Capital of 3.95%. This is in the lower half of the industry: PHI1 underperforms 63.24% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.63% | ||
| ROE | 1.56% | ||
| ROIC | 3.95% |
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 0.93%, PHI1 is doing worse than 63.24% of the companies in the same industry.
The Operating Margin of PHI1 (6.10%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of PHI1 has declined.
PHI1 has a Gross Margin of 43.49%. This is in the lower half of the industry: PHI1 underperforms 73.53% of its industry peers.
PHI1's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.1% | ||
| PM (TTM) | 0.93% | ||
| GM | 43.49% |
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PHI1 is destroying value.
The number of shares outstanding for PHI1 has been reduced compared to 1 year ago.
Compared to 5 years ago, PHI1 has more shares outstanding
The debt/assets ratio for PHI1 is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 2.01 indicates that PHI1 is not a great score, but indicates only limited risk for bankruptcy at the moment.
PHI1 has a Altman-Z score (2.01) which is comparable to the rest of the industry.
PHI1 has a debt to FCF ratio of 14.51. This is a negative value and a sign of low solvency as PHI1 would need 14.51 years to pay back of all of its debts.
PHI1's Debt to FCF ratio of 14.51 is on the low side compared to the rest of the industry. PHI1 is outperformed by 61.76% of its industry peers.
PHI1 has a Debt/Equity ratio of 0.69. This is a neutral value indicating PHI1 is somewhat dependend on debt financing.
PHI1 has a worse Debt to Equity ratio (0.69) than 73.53% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.69 | ||
| Debt/FCF | 14.51 | ||
| Altman-Z | 2.01 |
ROIC/WACC0.63
WACC6.29%
2.3 Liquidity
PHI1 has a Current Ratio of 1.32. This is a normal value and indicates that PHI1 is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.32, PHI1 is doing worse than 60.29% of the companies in the same industry.
A Quick Ratio of 0.86 indicates that PHI1 may have some problems paying its short term obligations.
PHI1 has a worse Quick ratio (0.86) than 66.18% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.32 | ||
| Quick Ratio | 0.86 |
3. Growth
3.1 Past
PHI1 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.15%, which is quite good.
Measured over the past years, PHI1 shows a decrease in Earnings Per Share. The EPS has been decreasing by -7.17% on average per year.
The Revenue has decreased by -1.43% in the past year.
The Revenue has been growing slightly by 1.00% on average over the past years.
EPS 1Y (TTM)15.15%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%12.5%
Revenue 1Y (TTM)-1.43%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-1.71%
3.2 Future
Based on estimates for the next years, PHI1 will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.28% on average per year.
PHI1 is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.00% yearly.
EPS Next Y4.35%
EPS Next 2Y4.98%
EPS Next 3Y7.73%
EPS Next 5Y10.28%
Revenue Next Year-2.27%
Revenue Next 2Y0.25%
Revenue Next 3Y1.58%
Revenue Next 5Y3%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
PHI1 is valuated rather expensively with a Price/Earnings ratio of 17.17.
Based on the Price/Earnings ratio, PHI1 is valued cheaply inside the industry as 92.65% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of PHI1 to the average of the S&P500 Index (27.19), we can say PHI1 is valued slightly cheaper.
With a Price/Forward Earnings ratio of 16.64, PHI1 is valued correctly.
Based on the Price/Forward Earnings ratio, PHI1 is valued a bit cheaper than 72.06% of the companies in the same industry.
PHI1's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.92.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.17 | ||
| Fwd PE | 16.64 |
4.2 Price Multiples
72.06% of the companies in the same industry are more expensive than PHI1, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of PHI1 is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 42.33 | ||
| EV/EBITDA | 13.28 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)3.95
PEG (5Y)N/A
EPS Next 2Y4.98%
EPS Next 3Y7.73%
5. Dividend
5.1 Amount
No dividends for PHI1!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
FRA:PHI1 (1/9/2026, 7:00:00 PM)
25.41
+0.1 (+0.4%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners44.83%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap24.47B
Revenue(TTM)17.78B
Net Income(TTM)165.00M
Analysts72.14
Price Target27.68 (8.93%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly Dividend0
Dividend Growth(5Y)-70.49%
DP199.39%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)22.57%
Min EPS beat(2)14.1%
Max EPS beat(2)31.04%
EPS beat(4)3
Avg EPS beat(4)13.85%
Min EPS beat(4)-11.97%
Max EPS beat(4)31.04%
EPS beat(8)3
Avg EPS beat(8)-0.89%
EPS beat(12)6
Avg EPS beat(12)18.79%
EPS beat(16)6
Avg EPS beat(16)4.51%
Revenue beat(2)0
Avg Revenue beat(2)-2.19%
Min Revenue beat(2)-2.4%
Max Revenue beat(2)-1.97%
Revenue beat(4)0
Avg Revenue beat(4)-2.34%
Min Revenue beat(4)-3.04%
Max Revenue beat(4)-1.96%
Revenue beat(8)0
Avg Revenue beat(8)-3.43%
Revenue beat(12)2
Avg Revenue beat(12)-1.64%
Revenue beat(16)2
Avg Revenue beat(16)-1.76%
PT rev (1m)0.41%
PT rev (3m)1.48%
EPS NQ rev (1m)1.31%
EPS NQ rev (3m)3.65%
EPS NY rev (1m)0.43%
EPS NY rev (3m)3.91%
Revenue NQ rev (1m)0.16%
Revenue NQ rev (3m)-0.39%
Revenue NY rev (1m)-0.4%
Revenue NY rev (3m)-0.45%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.17 | ||
| Fwd PE | 16.64 | ||
| P/S | 1.38 | ||
| P/FCF | 42.33 | ||
| P/OCF | 19.94 | ||
| P/B | 2.32 | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.28 |
EPS(TTM)1.48
EY5.82%
EPS(NY)1.53
Fwd EY6.01%
FCF(TTM)0.6
FCFY2.36%
OCF(TTM)1.27
OCFY5.01%
SpS18.47
BVpS10.96
TBVpS-1.42
PEG (NY)3.95
PEG (5Y)N/A
Graham Number19.1
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.63% | ||
| ROE | 1.56% | ||
| ROCE | 5.61% | ||
| ROIC | 3.95% | ||
| ROICexc | 3.95% | ||
| ROICexgc | 10.33% | ||
| OM | 6.1% | ||
| PM (TTM) | 0.93% | ||
| GM | 43.49% | ||
| FCFM | 3.25% |
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y10.6%
ROICexgc growth 5Y-2.51%
ROICexc growth 3Y4.73%
ROICexc growth 5Y-6.98%
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
F-ScoreN/A
Asset Turnover0.68
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.69 | ||
| Debt/FCF | 14.51 | ||
| Debt/EBITDA | 2.93 | ||
| Cap/Depr | 46.69% | ||
| Cap/Sales | 3.65% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 49.6% | ||
| Profit Quality | 350.3% | ||
| Current Ratio | 1.32 | ||
| Quick Ratio | 0.86 | ||
| Altman-Z | 2.01 |
F-ScoreN/A
WACC6.29%
ROIC/WACC0.63
Cap/Depr(3y)50.01%
Cap/Depr(5y)53.78%
Cap/Sales(3y)3.94%
Cap/Sales(5y)4.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.15%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%12.5%
EPS Next Y4.35%
EPS Next 2Y4.98%
EPS Next 3Y7.73%
EPS Next 5Y10.28%
Revenue 1Y (TTM)-1.43%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-1.71%
Revenue Next Year-2.27%
Revenue Next 2Y0.25%
Revenue Next 3Y1.58%
Revenue Next 5Y3%
EBIT growth 1Y712.43%
EBIT growth 3Y0.03%
EBIT growth 5Y-7.17%
EBIT Next Year48.95%
EBIT Next 3Y19.49%
EBIT Next 5Y15.13%
FCF growth 1Y-45.51%
FCF growth 3Y-40.93%
FCF growth 5Y-1.73%
OCF growth 1Y-31.12%
OCF growth 3Y-32.38%
OCF growth 5Y-4.03%
KONINKLIJKE PHILIPS NV / PHI1.DE FAQ
What is the ChartMill fundamental rating of KONINKLIJKE PHILIPS NV (PHI1.DE) stock?
ChartMill assigns a fundamental rating of 3 / 10 to PHI1.DE.
What is the valuation status for PHI1 stock?
ChartMill assigns a valuation rating of 4 / 10 to KONINKLIJKE PHILIPS NV (PHI1.DE). This can be considered as Fairly Valued.
How profitable is KONINKLIJKE PHILIPS NV (PHI1.DE) stock?
KONINKLIJKE PHILIPS NV (PHI1.DE) has a profitability rating of 2 / 10.
How financially healthy is KONINKLIJKE PHILIPS NV?
The financial health rating of KONINKLIJKE PHILIPS NV (PHI1.DE) is 2 / 10.
Can you provide the dividend sustainability for PHI1 stock?
The dividend rating of KONINKLIJKE PHILIPS NV (PHI1.DE) is 0 / 10 and the dividend payout ratio is 199.39%.